Monday, 23 November, 2015

Welcome!

Dr. Beatrix Förster joins CeNS as a new extraordinary member

 

Dr. Beatrix Förster is group leader at the Gene Center of the LMU developing novel antibody drugs for the treatment of antibiotic resistant bacteria. After graduating in Biomedical Sciences from the University of Marburg she did her PhD at the Max-Planck Institute of Biochemistry with Axel Ullrich. After contributing to the founding of Suppremol, a biotech company developing drugs for autoimmune diseases, she moved to Stanford University to do research in the field of allergy and asthma. After her return to Germany she was head of a laboratory developing novel anti-cancer drugs at TRION Research GmbH. Prior to becoming a group leader at LMU she worked as a project manager for clinical and translational projects at the Helmholtz Zentrum München.

Link to Dr. Förster's homepage